(Reuters) -Johnson & Johnson said on Tuesday it will withdraw a device to treat acid reflux disease from certain markets outside the United States, citing commercial reasons. The company has decided ...

Johnson & Johnson (NYSE:JNJ) will withdraw its LINX Reflux Management System—a device used to treat acid reflux disease—from markets outside the U.S. from March, according to a Bloomberg report that ...

One in five Americans suffers from gastroesophageal reflux disease (GERD), known colloquially as acid reflux. Acid reflux is a digestive disorder in in which acid backs up from the stomach into the ...

Johnson & Johnson is facing lawsuits stemming from the recall of some of its Linx reflux management devices for a manufacturing defect, highlighting the risks that come from such recalls. The Linx ...

*Refers to the latest 2 years of stltoday.com stories. Cancel anytime. ORLANDO, Fla. • For two years, Milagros Camacho struggled with what she thought was heartburn after every meal. At night stomach ...

March 17--At the Cuyuna Regional Medical Center in Crosby, a 145-bed hospital on the Iron Range, Dr. Paul Severson and Dr. Howard McCollister are two of only four surgeons in Minnesota implanting Linx ...

The FDA’s Gastroenterology-Urology Devices Panel voted unanimously that LINX’s Reflux Management System, a laparoscopically implanted device designed to treat gastroesophageal reflux disease, has a ...

FDA has announced it has approved Torax Medical’s LINX Reflux Management System for treatment of gastroesophageal reflux disease, according to a news release. The LINX Reflux Management System is a ...

If you’re among the 1 in 5 adults in the U.S. who have gastroesophageal reflux disease (GERD), you know how uncomfortable the symptoms can be. Chronic acid reflux can cause painful heartburn, ...